ProMIS Neurosciences (PMN) Share-based Compensation (IS) (2021 - 2026)
ProMIS Neurosciences' Share-based Compensation (IS) was $408,895 in Q2 2026, up 92.9% from $212,015 a year earlier and up 115.9% from the prior quarter.
Powered by 
Analysis
ProMIS Neurosciences (PMN) Share-based Compensation (IS) (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, ProMIS Neurosciences' Share-based Compensation (IS) was $998,638 through Jun 30, 2026, down 16.9% year-over-year; for FY2025, it was $857,628, up 3.9% from FY2024.
- Share-based Compensation (IS) shows a four-year compound annual growth rate of 13.6% (FY2021 to FY2025).
- In earlier years, Share-based Compensation (IS) was $825,808 in FY2024 (+204.1%), $271,542 in FY2023 (-44.3%), $487,630 in FY2022 (-5.4%) and $515,629 in FY2021.
- The Q2 2026 figure marks the highest quarterly Share-based Compensation (IS) since Q4 2024.
- Compared with a year earlier, Share-based Compensation (IS) was higher in three of the last six quarters, with growth averaging 56.9%.
- The best year-over-year quarter for Share-based Compensation (IS) over five years was Q1 2025 (growth of 285.8%); the worst was Q4 2023 (a decline of 94.6%).
- Per Business Quant data, PMN's Share-based Compensation (IS) in the three quarters before Q2 2026 was $189,425 (Q1 2026), $203,171 (Q4 2025) and $197,147 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | ProMIS Neurosciences | 95.51 Mn | -43.39 Mn | - | 408,895.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 408,895.00 |
| Mar 31, 2026 | 189,425.00 |
| Dec 31, 2025 | 203,171.00 |
| Sep 30, 2025 | 197,147.00 |
| Jun 30, 2025 | 212,015.00 |
| Mar 31, 2025 | 245,295.00 |
| Dec 31, 2024 | 623,189.00 |
| Sep 30, 2024 | 121,036.00 |
| Jun 30, 2024 | 17,999.00 |
| Mar 31, 2024 | 63,584.00 |
| Dec 31, 2023 | 4,841.00 |
| Sep 30, 2023 | 134,191.00 |
| Jun 30, 2023 | 134,191.00 |
| Mar 31, 2023 | 132,510.00 |
| Dec 31, 2022 | 90,150.00 |
| Sep 30, 2022 | 108,584.00 |
| Jun 30, 2022 | 116,943.00 |
| Mar 31, 2022 | 124,865.00 |
| Dec 31, 2021 | 118,149.00 |
| Sep 30, 2021 | 189,629.00 |
API Access
ProMIS Neurosciences Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PMN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "PMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();